Company / Shareholders' Equity
Fortress Biotech, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$49.9M
FY2025
5-year range
$22.5M / $108.7M
FY2021-FY2025
Trend
+119.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $2M in FY2018 to $109M in FY2021.
Based on SEC 10-K filings.
$50M in FY2025 with a 5-year CAGR of +13.7%.
Improved from $23M to $50M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.7%, indicating consistent growth.
- In FY2025, shareholders' equity increased 119.3% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.9M | +119.3% |
| FY2024 | $22.7M | +0.9% |
| FY2023 | $22.5M | -46.0% |
| FY2022 | $41.7M | -61.6% |
| FY2021 | $108.7M | +314.5% |
| FY2020 | $26.2M | +0.0% |
| FY2019 | $26.2M | +1315.5% |
| FY2018 | $1.9M | -96.5% |
| FY2017 | $52.6M | +36.6% |
| FY2016 | $38.5M | -32.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026